Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-02222-0.pdf
Reference62 articles.
1. IARC, W. GLOBOCAN: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012 (IARC, 2014).
2. Brenton, J. D., Carey, L. A., Ahmed, A. A. & Caldas, C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23, 7350–7360, doi: 10.1200/jco.2005.03.3845 (2005).
3. Anders, C. K. & Carey, L. A. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clinical breast cancer 9(Suppl 2), S73–81, doi: 10.3816/CBC.2009.s.008 (2009).
4. Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. The New England journal of medicine 363, 1938–1948, doi: 10.1056/NEJMra1001389 (2010).
5. Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clinical cancer research: an official journal of the American Association for Cancer Research 13, 4429–4434, doi: 10.1158/1078-0432.ccr-06-3045 (2007).
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability;Acta Pharmaceutica Sinica B;2024-08
2. Multifaceted role of phytoconstituents based nano drug delivery systems in combating TNBC: A paradigm shift from chemical to natural;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-02
3. Lovastatin-Induced Mitochondrial Oxidative Stress Leads to the Release of mtDNA to Promote Apoptosis by Activating cGAS-STING Pathway in Human Colorectal Cancer Cells;Antioxidants;2024-05-31
4. Phytochemistry and pharmacology of alkaloids from Papaver spp.: a structure–activity based study;Phytochemistry Reviews;2024-05-02
5. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors;Pharmaceuticals;2024-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3